by Aspirion | Jul 1, 2026 | Artificial Intelligence (AI), Denials Management, Revenue Cycle Management
Experimental and investigational denials are some of the most frustrating claim denials providers face. A procedure may be FDA approved, medically necessary, and even authorized, yet still denied as “experimental” or “non-covered.” In this...
by Aspirion | Jun 17, 2026 | Artificial Intelligence (AI), Denials Management, Revenue Cycle Management
We sat down with Chief AI Officer Spencer Allee and Chief Technology Officer Curtis McGinnis for an honest, plain-language discussion on how AI and automation are actually working in healthcare revenue cycle and what health systems and hospitals should understand...
by Aspirion | Jun 3, 2026 | Artificial Intelligence (AI), Legislation, Out-of-Network Recovery, Payment Variance Recovery, Revenue Cycle Management
A long-awaited rule overhauling the federal Independent Dispute Resolution (IDR) process established under the No Surprises Act (NSA)—the landmark consumer protection law designed to shield patients from unexpected out-of-network medical bills—was finalized last week....
by Aspirion | May 28, 2026 | Artificial Intelligence (AI), Denials Management, Revenue Cycle Management
The following is an edited Q&A based on remarks from Aspirion’s Liana Hamilton, President, Payment Variance Recovery, and Chase McGrath, Vice President of Product, delivered during a recent webinar hosted by the Healthcare Financial Management...
by Aspirion | May 13, 2026 | Artificial Intelligence (AI), Denials Management, Revenue Cycle Management
The insights and clinical expertise shared in this post and the Q12026 Policy Payer Playbook included were generously contributed by Autumn Resch, Lead Clinical Nurse Specialist, and Melony Malone Norwood, Lead Clinical Nurse Specialist. We are grateful for their...
by Aspirion | May 6, 2026 | Artificial Intelligence (AI), Denials Management, Revenue Cycle Management
In this Q&A, Aspirion’s Rikki Ashkin, J.D., Senior Client Success Director, and Thomas Page, J.D., Sr. Director Ops Insights & Enablement, break down what extenuating circumstances are, how they apply across common authorization denial scenarios, and why...
